ABSTRACT
Implications .................................................................................................236 14.8 Methylation Profiling of Tumor Cells and Tumor DNA in Urine from
Patients with Cancer ...................................................................................237 14.9 Methylation Profiling of Tumor Cells and Tumor DNA in Other Body
Fluids from Patients with Cancer ...............................................................237 14.10 Qualitative and Quantitative Analyses of Aberrant Methylation
Changes: Sensitivity and Specificity ..........................................................239 14.11 High-Throughput Methods for Methylation Profiling in Cancer Cells
and the Selection of Target Genes as Epigenetic Markers in Blood and Body Fluids ..........................................................................................240
References..............................................................................................................241
